https://www.selleckchem.com/pr....oducts/bay-61-3606.h
After ECs were incubated with NETs isolated from stage III/IV glioma patients, they lost their intercellular connections and were converted into procoagulant phenotypes. Combining DNase I and activated protein C markedly decreased endothelial dysfunction. Our results showed the interaction between NETs and hypercoagulability in glioma patients. Targeting NETs may be a potential therapeutic and prevention direction for thrombotic complications in glioma patients. Our results showed the interaction between NETs and hypercoagulability
Curtir
Comentario
Compartilhar
